The U.S Pharmacopeia is implementing a program to support the public health response to the COVID-19 pandemic. The immediate work is focusses on the following activities:

-        Immediate Access to quality public guidelines: Selection of general chapters and monographies critical for the development of vaccines and antiviral medication of the United States Pharmacopeia – National Formulary (USP-NF) are available for free to developers of antiviral medication and vaccines for COVID-19. Access here the USP-NF: 

-        Support for developers of antiviral medication and vaccines for COVID-19: The U.S. Pharmacopeia is offering technical assistance for free for developers and manufacturers of vaccines and medication, in order to make the development and production of COVID-19 medication easier. Access additional information here: 

Additional information can be accessed in:, or by direct contact with the U.S. Pharmacopeia – Brazil (